The case studies presented here describe the application of V.A.C. VERAFLO™ Therapy for a variety of wound types you may encounter. Learn how these interesting and challenging cases were managed and review the results seen following treatment with V.A.C. VERAFLO™ Therapy.
As with any case study, the results and outcomes should not be interpreted as a guarantee or warranty of similar results. Individual results may vary, depending on the patient’s circumstances and condition.
Case Study 1: Trauma of the Ankle
A 69-year-old female presented with an open fracture of the left lateral malleolus. Following debridement, V.A.C. VERAFLO™ Therapy with saline solution was applied for 9 days.
Case Study 2: Trauma of the Knee
A 22-year-old male presented with an open fracture of the left knee with a skin defect on the anterior knee caused by a motorcycle accident. The patient developed a skin infection on Day 3, and V.A.C. VERAFLO™ Therapy with saline solution was applied for 9 days.
Case Study 3: Contaminated Ileostomy Site
An 83-year-old male presented with an open post-operative contaminated wound at a previous ileostomy site. V.A.C. VERAFLO™ Therapy with Microcyn® solution was applied for 12 days.
Case Study 4: Infected Chest Wound
A 43-year-old female presented with an infected chest wound after radiation, and V.A.C. VERAFLO™ Therapy with Prontosan® Wound Irrigation Solution was applied for 3 days.
Case Study 5: Infected Foot Abscess
An 86-year-old female diabetic with peripheral vascular disease presented with a left-foot abscess, and V.A.C. VERAFLO™ Therapy with saline solution was applied for 3 days.
Case Study 6: Infected Foot Wound
A 74-year-old male with hypertension presented with an infected neuropathic wound located on his right foot, and V.A.C. VERAFLO™ Therapy with Lactated Ringer’s Solution was applied for 9 days.
Case Study 7: Infected Diabetic Foot Wound
A 56-year-old male diabetic presented with an infected diabetic foot ulcer, and V.A.C. VERAFLO™ Therapy with Lactated Ringer’s Solution was applied for 6 days.
Case Study 8: Infected Trauma Wound
A 67-year-old male presented with an infected trauma wound, and V.A.C. VERAFLO™ Therapy with saline solution followed by Lactated Ringer’s Solution was applied for 7 days.
Case Study 9: Lower Extremity Wound
A 44-year-old female presented following an aggressive debridement of her right lower extremity to treat necrotizing fasciitis. V.A.C. VERAFLO™ Therapy with Clorpactin® WCS-90 solution was applied for 6 weeks.
Case Study 10: Abdominal Wound
A 76-year-old female presented 13 days post-op following a ventral hernia repair with hypotension, dehydration, and leukocytosis. Following percutaneous drainage and subsequent open operative incision and drainage and removal of the mesh, V.A.C. VERAFLO™ Therapy with Microcyn® solution was applied for 9 days.
Case Study 11: Dehisced and Infected Lobule Post Excision
A 63-year-old morbidly obese female admitted to the inpatient nursing unit with an infected right thigh lobule excision of a massive localized lobule. V.A.C. VERAFLO™ Therapy with 0.25% acetic acid and saline was applied for 7 days.
Case Study 12: Pressure Ulcer
A 63-year-old female presented with a pressure ulcer to the left flank following a fall. V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO CLEANSE CHOICE™ Dressing was applied.
Case Study 13: Pressure Ulcer
A 64 year-old presented with a stage 4 pressure ulcer of the sacrum present for more than 4 years. V.A.C. VERAFLO™ Therapy with V.A.C. VERAFLO CLEANSE CHOICE™ Dressing was applied.
Case Study 14: Lower Extremity with Orthopedic Hardware-Related Infection
A 62-year-old female was admitted to the hospital with a hardware-related infection, osteomyelitis, and wound breakdown. Due to concerns regarding tendon and hardware exposure, no further surgical debridements could be performed. V.A.C.® Therapy was discontinued in favor of V.A.C. VERAFLO™ Therapy using V.A.C. VERAFLO CLEANSE CHOICE™ Dressings.
Clorpactin is a registered trademark of United Guardian, Inc. Microcyn is a registered trademark of Oculus Innovative Sciences, Inc. Prontosan is a registered trademark of B. Braun Medical, Inc.
Case Study Submission
A picture is worth a thousand words! We invite you to submit an original patient case study for possible inclusion on VERAFLO.com! The aim of the case studies is to provide practical insights into the application of V.A.C. VERAFLO™ Therapy to help your colleagues in their wound care management. We want to know what you’re doing, what works, and why; and if it’s not working, why not. The advantage is that we learn from real cases.
To submit your case study, please fill out the form below. If your case study is accepted following review by our Medical Affairs group, we will contact you regarding compensation and to obtain additional study details.